CN Stock MarketDetailed Quotes
600488 Tianjin Tianyao Pharmaceuticals
- 3.51
- 0.000.00%
Market Closed Jul 12 15:00 CST
3.84BMarket Cap35.82P/E (TTM)
3.56High3.49Low42.77KlotVolume3.51Open3.51Pre Close15.06MTurnover0.39%Turnover Ratio32.80P/E (Static)1.09BShares5.4952wk High1.32P/B3.83BFloat Cap3.0152wk Low3.86Limit Up1.09BShs Float12.99Historical High3.16Limit Down1.99%Amplitude0.98Historical Low0.09Dividend TTM3.52Avg Price20.69KlotAsk2.48%Div YieldTTM100Lot Size21.79KlotBid
Tianjin Tianyao Pharmaceuticals Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.71%785.11M | -1.55%3.42B | -0.73%2.47B | 11.49%1.71B | 36.12%815.38M | 9.25%3.48B | 15.73%2.49B | 12.18%1.53B | -12.49%599.03M | 19.45%3.18B |
| Refunds of taxes and levies | 46.71%32.41M | 1.04%114.23M | 0.30%83.43M | -9.68%49.5M | -18.74%22.09M | 24.07%113.05M | 32.72%83.18M | 38.26%54.8M | 24.47%27.19M | -12.25%91.12M |
| Net deposit increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | 0.59%16.65M | 9.64%97.34M | -10.81%72.82M | -6.32%58.84M | -67.40%16.55M | -10.43%88.79M | -1.41%81.65M | -10.72%62.81M | 75.03%50.77M | 50.24%99.13M |
| Cash inflows from operating activities | -2.32%834.17M | -1.20%3.64B | -1.01%2.62B | 10.11%1.81B | 26.15%854.02M | 9.08%3.68B | 15.57%2.65B | 11.79%1.65B | -7.94%676.99M | 19.00%3.37B |
| Goods services cash paid | 16.54%501.8M | -14.51%1.88B | -10.95%1.43B | -2.09%1B | 9.85%430.58M | -2.24%2.2B | 7.60%1.61B | 4.05%1.03B | -16.65%391.98M | 34.57%2.25B |
| Staff behalf paid | 52.96%169.29M | 5.34%427.12M | 12.87%311.67M | 12.92%203.07M | 13.70%110.68M | 5.38%405.45M | 5.59%276.12M | 4.29%179.83M | 7.40%97.34M | -3.47%384.77M |
| All taxes paid | -5.20%71.83M | 10.21%308.66M | 9.91%237.61M | 12.25%162.25M | 5.36%75.77M | 7.60%280.06M | 17.88%216.18M | 42.38%144.54M | 19.19%71.92M | 10.55%260.28M |
| Net loan and advance increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net lend capital | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -27.08%39.7M | 66.39%238.36M | 79.70%179.39M | 80.86%130.09M | 21.65%54.44M | -12.56%143.25M | -24.87%99.82M | -26.12%71.93M | 64.90%44.75M | -10.77%163.82M |
| Cash outflows from operating activities | 16.55%782.62M | -5.73%2.85B | -1.79%2.16B | 5.46%1.5B | 10.80%671.46M | -1.00%3.03B | 6.18%2.2B | 4.78%1.42B | -6.54%605.99M | 22.86%3.06B |
| Net cash flows from operating activities | -71.76%51.55M | 19.81%783.01M | 2.77%465.39M | 39.52%313.76M | 157.12%182.56M | 106.23%653.52M | 102.63%452.86M | 93.57%224.89M | -18.40%71M | -8.65%316.89M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --3.37M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -74.77%1.03M | --26.11K | ---- | ---- | 494.52%4.07M | ---- | ---- | ---- | 75.41%683.98K |
| Net cash received from disposal of subsidiaries and other business units | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | ---- | -74.77%1.03M | --26.11K | ---- | ---- | 0.30%4.07M | ---- | ---- | ---- | -71.83%4.05M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -12.47%24.12M | -34.15%133.15M | -35.01%89.97M | -49.62%48.95M | -49.73%27.56M | -45.48%202.2M | -51.54%138.44M | -51.11%97.16M | -23.08%54.82M | -19.12%370.84M |
| Cash paid to acquire investments | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | -92.74%10.17M |
| Impawned loan net increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --400K | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -11.02%24.52M | -34.15%133.15M | -35.01%89.97M | -49.62%48.95M | -49.73%27.56M | -46.93%202.2M | -53.20%138.44M | -53.49%97.16M | -32.69%54.82M | -36.34%381.01M |
| Net cash flows from investing activities | 11.02%-24.52M | 33.32%-132.12M | 35.03%-89.94M | 49.62%-48.95M | 49.73%-27.56M | 47.44%-198.13M | 52.58%-138.44M | 53.43%-97.16M | 32.69%-54.82M | 35.47%-376.96M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from borrowing | 80.36%101M | -47.15%580.5M | -47.15%580.5M | -4.25%515.5M | -30.35%56M | -28.05%1.1B | -23.76%1.1B | -41.91%538.4M | -80.31%80.4M | -25.30%1.53B |
| Cash received relating to other financing activities | ---- | --0 | ---- | --0 | ---- | -11.43%155M | -11.43%155M | 6.90%155M | 5.00%105M | -31.12%175M |
| Cash inflows from financing activities | 80.36%101M | -53.69%580.5M | -53.69%580.5M | -25.66%515.5M | -69.80%56M | -26.34%1.25B | -22.38%1.25B | -35.31%693.4M | -63.53%185.4M | -26.60%1.7B |
| Borrowing repayment | -11.48%130.5M | -13.83%995.57M | -13.85%994.07M | 8.28%729.93M | -7.92%147.43M | -4.44%1.16B | -2.44%1.15B | -5.87%674.1M | -60.07%160.11M | -37.91%1.21B |
| Dividend interest payment | -8.77%8.33M | -15.34%67M | -20.78%43.94M | -12.15%28.93M | 3.09%9.13M | 7.13%79.15M | 22.26%55.47M | 1.50%32.92M | -15.99%8.86M | -27.71%73.88M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | 1.92%19.25M | ---- | ---- | ---- | 20.61%18.89M | --8.8M | ---- | ---- | -25.94%15.66M |
| Cash payments relating to other financing activities | -99.90%28.41K | 12.60%82.78M | 90.22%82.78M | 90.22%82.78M | 742.70%27.28M | -77.45%73.52M | -85.54%43.52M | -82.66%43.52M | -96.77%3.24M | 244.87%326.08M |
| Cash outflows from financing activities | -24.46%138.86M | -12.43%1.15B | -10.54%1.12B | 12.14%841.63M | 6.76%183.83M | -18.70%1.31B | -18.06%1.25B | -24.91%750.54M | -66.35%172.2M | -24.95%1.61B |
| Net cash flows from financing activities | 70.38%-37.86M | -935.01%-564.85M | -92,076.63%-540.29M | -470.77%-326.13M | -1,068.14%-127.83M | -158.88%-54.57M | -99.32%587.42K | -179.01%-57.14M | 486.20%13.2M | -46.84%92.69M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 484.29%6.11M | 1,284.50%8.17M | -143.73%-5.53M | -218.26%-10.84M | -227.49%-1.59M | -55.49%589.81K | 3,075.59%12.64M | 6,514.15%9.17M | 540.50%1.25M | 154.56%1.33M |
| Net increase in cash and cash equivalents | -118.47%-4.72M | -76.53%94.2M | -152.00%-170.37M | -190.47%-72.16M | -16.51%25.57M | 1,082.25%401.41M | 1,743.96%327.65M | 493.28%79.76M | 1,536.85%30.63M | 151.98%33.95M |
| Add:Begin period cash and cash equivalents | 15.47%703.01M | 193.55%608.8M | 193.55%608.8M | 193.55%608.8M | 193.55%608.8M | 19.58%207.4M | 19.58%207.4M | 19.58%207.4M | 19.58%207.4M | -27.36%173.44M |
| End period cash equivalent | 10.07%698.28M | 15.47%703.01M | -18.06%438.43M | 86.89%536.65M | 166.51%634.38M | 193.55%608.8M | 179.82%535.04M | 87.48%287.15M | 35.77%238.03M | 19.58%207.4M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | CITIC Certified Public Accountants (Special General Partnership) | -- | -- | -- | CITIC Certified Public Accountants (Special General Partnership) | -- | -- | -- | CITIC Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg